Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAP for ISSHL with OSA
NCT04192656Phase 4Recruiting
- Sponsor
- Beijing Tsinghua Changgung Hospital
- Start
- Nov 2019
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in idiopathic sudden sensorineural hearing loss (ISSNHL) and obstructive sleep apnea (OSA) (2 arms), sponsored by Beijing Tsinghua Changgung Hospital. Primary endpoint: hearing threshold at 3 months. Started Nov 2019; status: recruiting.
02
Conditions
idiopathic sudden sensorineural hearing loss (ISSNHL)obstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT04192656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04192656.